W
EW icon

WealthCollab’s Edwards Lifesciences EW Stock Holding History

WealthCollab’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.2K Hold
227
– – 0.01% 394
2025
Q4 		$19.4K Hold
227
– – 0.01% 407
2025
Q3 		$17.7K Buy
227
+13
+6% +$1.02K 0.01% 384
2025
Q2 		$16.7K Buy
214
+104
+95% +$7.76K 0.01% 367
2025
Q1 		$7.97K Buy
110
+53
+93% +$3.79K ﹤0.01% 514
2024
Q4 		$4.22K Hold
57
– – ﹤0.01% 626
2024
Q3 		$3.76K Buy
+57
New +$4.14K ﹤0.01% 670

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

WealthCollab's EW Position: Q1 2026 in Review

WealthCollab held its Edwards Lifesciences (EW) position steady in Q1 2026 at 227 shares worth $18.2K. The position accounts for 0.01% of the portfolio, ranked #394.

WealthCollab first reported a position in EW in Q3 2024 and has held it in 7 quarters since. The position peaked at $19.4K in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • WealthCollab held 227 shares of Edwards Lifesciences worth $18.2K as of Q1 2026.
  • WealthCollab left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.01% of WealthCollab's portfolio in Q1 2026, its #394 holding.
  • WealthCollab first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 7 quarters since.
  • WealthCollab's Edwards Lifesciences position peaked at $19.4K in Q4 2025.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.